David Soriano Castell

Dr. David Soriano Castell

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2022 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ZLZhibin Liang
Zhibin Liang
DCDavid Soriano Castell
David Soriano Castell
DKDevin Kepchia
Devin Kepchia
BDBrendan Duggan
Brendan Duggan
ACAntonio Currais
Antonio Currais
Pamela MaherPamela Maher
Pamela Maher

26 December 2018 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
VBVictoria J Butler
Victoria J Butler
DSDominique A Salazar
Dominique A Salazar
DCDavid Soriano Castell
David Soriano Castell
MAMiguel Alves-Ferreira
Miguel Alves-Ferreira
FDFrank J A Dennissen
Frank J A Dennissen
AKAimee W Kao
Aimee W Kao
Mutations in the microtubule-associated protein tau (MAPT) underlie multiple neurodegenerative disorders, yet the pathophysiological mechanisms are unclear. A novel variant in MAPT resulting in an alanine to threonine substitution at position 152 (A152T tau) has recently been described as a significant risk factor for both frontotemporal lobar degeneration and Alzheimer’s disease. Here we use complementary computational, biochemical, molecular, genetic and imaging approaches in Caenorhabditis elegans and mouse models to interrogate the effects of the A152T variant on tau function. In silico analysis suggests that a threonine at position 152 of tau confers a new phosphorylation site. This finding is borne out by mass spectrometric survey of A152T tau phosphorylation in C. elegans and mouse. Optical pulse-chase experiments of Dendra2-tau demonstrate that A152T tau and phosphomimetic A152E tau exhibit increased diffusion kinetics and the ability to traverse across the axon initial segment more efficiently than wild-type (WT) tau. A C. elegans model of tauopathy reveals that A152T and A152E tau confer patterns of developmental toxicity distinct from WT tau, likely due to differential effects on retrograde axonal transport. These data support a role for phosphorylation of the variant threonine in A152T tau toxicity and suggest a mechanism involving impaired retrograde axonal transport contributing to human neurodegenerative disease.

30 July 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KMKayalvizhi Madhivanan
Kayalvizhi Madhivanan
EGErin R. Greiner
Erin R. Greiner
MAMiguel Alves-Ferreira
Miguel Alves-Ferreira
DCDavid Soriano Castell
David Soriano Castell
NRNirvan Rouzbeh
Nirvan Rouzbeh
SESandra E. Encalada
Sandra E. Encalada
Significance: Evidence suggests that transthyretin (TTR) amyloid diseases result from rate-limiting dissociation of TTR tetramers secreted from the liver into monomers, followed by monomer misfolding and misassembly into a spectrum of aggregates that compromise postmitotic tissue function, including peripheral nerve function. It is unknown how TTR aggregation leads to the demise of neurons cell nonautonomously. Herein we introduce transgenic Caenorhabditis elegans models of TTR amyloidosis that exhibit aggregation and quantifiable cell nonautonomous neuronal phenotypes, including impaired pain sensation, as seen in humans, and altered neuronal morphology. Neuronal dysfunction can be exacerbated by eliminating distal macrophage-like cells that degrade TTR and ameliorated by treating the transgenic worms with TTR RNAi or a TTR kinetic stabilizer, strategies that also delay human polyneuropathy.

10 January 2014 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MSMarta Soler
Marta Soler
MGMarta González-Bártulos
Marta González-Bártulos
DCDavid Soriano Castell
David Soriano Castell
XRXavi Ribas
Xavi Ribas
MCMiquel Costas
Miquel Costas
Marta PlanasMarta Planas
Marta Planas
Antimicrobial peptides are an interesting source of non-cytotoxic drug delivery vectors. Herein, we report on the identification of a new cell-penetrating peptide (KKLFKKILKKL-NH2, BP16) from a set of antimicrobial peptides selected from a library of cecropin-melittin hybrids (CECMEL11) previously designed to be used in plant protection. This set of peptides was screened for their cytotoxicity against breast adenocarcinoma MCF-7, pancreas adenocarcinoma CAPAN-1 and mouse embryonic fibroblast 3T3 cell lines. BP16 resulted to be non-toxic against both malignant and non-malignant cells at concentrations up to 200 μM. We demonstrated by flow cytometry and confocal microscopy that BP16 is mainly internalized in the cells through a clathrin dependent endocytosis and that it efficiently accumulates in the cell cytoplasm. We confirmed that the cell-penetrating properties of BP16 are retained after conjugating it to the breast tumor homing peptide CREKA. Furthermore, we assessed the potential of BP16 as a drug delivery vector by conjugating the anticancer drug chlorambucil to BP16 and to a CREKA-BP16 conjugate. The efficacy of the drug increased between 6 and 9 times when conjugated to BP16 and between 2 and 4.5 times when attached to the CREKA-BP16 derivative. The low toxicity and the excellent cell-penetrating properties clearly suggest that BP16 is a suitable vector for the delivery of therapeutic agents into cells.

26 August 2011 in Traffic
Verified
Journal Article
Open access
PDF file
MVMaite Vidal‐Quadras
Maite Vidal‐Quadras
MGMariona Gelabert‐Baldrich
Mariona Gelabert‐Baldrich
DCDavid Soriano Castell
David Soriano Castell
ALAnna Lladó
Anna Lladó
CRCarles Rentero
Carles Rentero
FTFrancesc Tebar
Francesc Tebar
The main cellular Ca2+ sensor, calmodulin (CaM), interacts with and regulates several small GTPases, including Rac1. The present study revealed high binding affinity of Rac1 for CaM and uncovered two new essential binding domains in Rac1: the polybasic region, important for phosphatidylinositol-4-phosphate 5-kinase (PIP5K) interaction, and the adjacent prenyl group. CaM inhibition increased Rac1 binding to PIP5K and induced an extensive phosphatidylinositol 4,5-bisphosphate (PI4,5P2)-positive tubular membrane network. Immunofluorescence demonstrated that the tubules were plasma membrane invaginations resulting from an ADP-ribosylation factor 6 (ARF6)-dependent and clathrin-independent pathway. The role of Rac1 in this endocytic route was analyzed by expressing constitutively active and inactive mutants. While active Rac1 impaired tubulation, the inactive mutant enhanced it. Intriguingly, inactive mutant expression elicited tubulation by recruiting PIP5K and inhibiting Rac1 at the plasma membrane. Accordingly, CaM inhibition inactivated Rac1 and increased Rac1/PIP5K interaction. Therefore, our findings highlight an important new role for Rac1 and CaM in controlling clathrin-independent endocytosis.

9 April 2014 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MGMariona Gelabert‐Baldrich
Mariona Gelabert‐Baldrich
DCDavid Soriano Castell
David Soriano Castell
MCMaria Calvo
Maria Calvo
ALAlbert Lu
Albert Lu
AVArnau Viña‐Vilaseca
Arnau Viña‐Vilaseca
FTFrancesc Tebar
Francesc Tebar
The endocytic compartment is emerging as a functional platform for controlling important cellular processes. We have found that ~10 to 15% of total KRas, a protein that is frequently mutated in cancer, is present on endosomes, independent of its activation state. The dynamics of GFP‐KRas wild‐type (WT) and constitutively active or inactive mutants on endosomes were analyzed by fluorescence recovery after photobleaching (FRAP) microscopy. The measurements revealed an extraordinarily fast recovery of KRas WT [half‐time (HT), ~1.3 s] compared to HRas, Rab5, and EGFR, with the active KRasG12V mutant being significantly faster and more mobile (HT, ~1 s, and ~82% of exchangeable fraction) than the inactive KRasS17N (HT, ~1.6 s, and ~60% of exchangeable fraction). KRas rapidly switches from the cytoplasm to the endosomal membranes by an electrostatic interaction between its polybasic region and the endosomal acidic phospholipids, mainly phosphatidylserine.—Gelabert‐Baldrich, M., Soriano‐Castell, D., Calvo, M., Lu, A., Viña‐Vilaseca, A., Rentero, C., Pol, A., Grinstein, S. Enrich, C., Tebar, F. Dynamics of KRas on endosomes: involvement of acidic phospholipids in its association. FASEB J . 28, 3023–3037 (2014). www.fasebj.org